Interventional technology firm Cook Medical has completed enrollment in an international clinical trial of its Zilver PTX drug-eluting peripheral stent.
The 420 patients enrolled in the randomized trial include patients with peripheral arterial disease treated in Germany, the U.S., and Japan, according to the Bloomington, IN-based firm. Cook said it has also enrolled an additional 780 patients from the European Union, Canada, and Korea in a clinical registry to evaluate the safety of Zilver PTX.
Related Reading
Cook wins injunction against Endologix, April 1, 2008
Cook begins Reform clinical trial, March 20, 2008
Cook debuts new AAA graft, November 14, 2007
Cook receives FDA nod for Zenith stent trial, September 24, 2007
Cook expands existing Cardica deal, September 20, 2007
Copyright © 2008 AuntMinnie.com
